Its relevance comes from emphasizing the importance of broadening cardiovascular risk assessment in AS beyond conventional lipid measures, indicating that biomarkers such as Klotho, which, together with LDL and HDL subclasses, may provide a more detailed understanding of subclinical atherosclerosis in this patient group. The gene discussed is KL; the disease is atherosclerosis.